Symbol Lookup

Thursday June 20, 2013 5:42 AM ET. Data delayed 15 minutes.
12.21
0.00 (0.00%)
Bid/Lots
11.75/1
Ask/Lots
16.00/5
Open/Prev Close
0.00/12.21
Day Range
-----
52-Week Range
10.00-27.08
Vol/Avg Daily Vol
0.0/666.5K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

MAKO Headlines

Go
MAKO Surgical Corp. Announces Addition of Senior Executive to Management Team
4:05PM ET on Monday Jun 03, 2013 by GlobeNewswire
Companies Mentioned: MAKO, SNN

MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO(R) Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty(R) joint specific applications and proprietary RESTORIS(R) implants that together enable orthopedic surgeons to consistently, reproducibly and precisely treat patient specific osteoarthritic disease, today announced that Ian Dawson has been appointed to the position of Senior Vice President of Marketing, assuming responsibility for MAKO's commercial marketing activities, which were formerly overseen by Ivan Delevic, who is transitioning to the position of Senior Vice President of Corporate Development. Mr. Dawson and Mr. Delevic will report to Maurice R. Ferre, M.D., MAKO's President and Chief Executive Officer.

MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets its RIO(R) Robotic Arm Interactive Orthopedic surgical platform, MAKOplasty(R) joint specific applications and proprietary RESTORIS(R) implants that together enable orthop...

May 28, 2013

Analyst Actions: MAKO Surgical Jumps 13% as Wells Fargo Upgrades to Outperform, Raises PT
1:49PM ET on Tuesday May 28, 2013 by Midnight Trader
Companies Mentioned: MAKO
01:49 PM EDT, 05/28/2013 (MidnightTrader) -- Shares in MAKO Surgical (MAKO) are up 13% to $12.68 after analysts at Wells Fargo upped their rating on the stock to Outperform from Market Perform. The firm raised the price target to $16 from $11.50 a s...
01:49 PM EDT, 05/28/2013 (MidnightTrader) -- Shares in MAKO Surgical (MAKO) are up 13% to $12.68 after analysts at Wells Fargo upped their rating on the stock to Outperform from Market Perform. The firm raised the price target to $16 from $11.50 ...

Peers Headlines

Jun 12, 2013

Sequenom Opens New Lab Facility In North Carolina
7:26AM ET on Wednesday Jun 12, 2013 by Midnight Trader
Companies Mentioned: SQNM
07:26 AM EDT, 06/12/2013 (MidnightTrader) -- Life sciences company Sequenom, Inc. (SQNM) announced that its wholly owned subsidiary, the Sequenom Center for Molecular Medicine, has completed the build-out and validation of an additional laborator...
Sequenom CMM Opens New CLIA Lab Facility In North Carolina
7:00AM ET on Wednesday Jun 12, 2013 by PR Newswire
Companies Mentioned: SQNM

Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed the build-out and...

May 31, 2013

Sequenom, Inc. [SQNM] to Ring The NASDAQ Stock Market Opening Bell
10:00AM ET on Friday May 31, 2013 by GlobeNewswire
Companies Mentioned: NDAQ, SQNM

What:

Sequenom, Inc. [SQNM], a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions, will visit the NASDAQ MarketSite in Times Square.

In honor of the occasion, Harry Hixson Jr.,...

May 30, 2013

Sequenom Inks License and Marketing Agreements With Laboratoire Cerba In France
7:55AM ET on Thursday May 30, 2013 by Midnight Trader
Companies Mentioned: SQNM
07:55 AM EDT, 05/30/2013 (MidnightTrader) -- Sequenom (SQNM) and its wholly owned subsidiary, Sequenom Center for Molecular Medicine, have entered into technology licensing and marketing agreements with Laboratoire Cerba in France for noninvasive...
Sequenom Announces License And Marketing Agreements With Laboratoire Cerba In France
7:00AM ET on Thursday May 30, 2013 by PR Newswire
Companies Mentioned: SQNM

Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that it, along with its wholly owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), has entered into tec...

May 28, 2013

Sequenom Announces Participation At The Jefferies Global Healthcare Conference
7:00AM ET on Tuesday May 28, 2013 by PR Newswire
Companies Mentioned: SQNM

Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Jefferies 2013 Global Healthcare Conference at the Grand Hyatt in ...